Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Nachrichtenquelle: globenewswire
25.03.2021, 20:48  |  152   |   |   

Orphazyme A/S
Company announcement                                                                                       

No. 11/2021                                                                                                           
Company Registration No. 32266355

Copenhagen, Denmark, March 25, 2021 – Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), hereby notifies receipt of information of the following transactions in Orphazyme’s shares by persons discharging managerial responsibilities in Orphazyme:

Details of the Reporting Person / Closely Associated Person
a) Name
Catherine Moukheibir
Reason for the notification
a) Position/status
Member of the Board of Directors
b) Initial notification/Amendment
Initial notification
Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Orphazyme A/S
b) LEI code
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code
ISIN DK0060910917
b) Nature of the transaction
Exercise of Restricted Share Units
c) Price(s) and volume(s)

Price(s)  Volume(s)
 DKK 61.1895 1,927

d) Aggregated information
Aggregated volume: 1,927 shares
Aggregated price: DKK 117,912.17
Price per share (volume weighted average): DKK 61.1895
e) Date of the transaction
March 24, 2021

Seite 1 von 4
Orphazyme Bearer and/or registered Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren



Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities Orphazyme A/SCompany announcement                                                                                       No. 11/2021                                                                                                           Company …

Nachrichten des Autors